Stay updated with breaking news from Gavin Herbert Eye. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Skye Bioscience, Inc. , a pharmaceutical company developing drugs targeting the endocannabinoid system, initially through modulation of the CB1 receptor, to address diseases including glaucoma and...
Share this article Share this article NEWPORT BEACH, Calif., May 5, 2021 /PRNewswire/ --Ceyeber's intraocular lenses are designed for medical applications and will be medical-grade. To ensure expert clinical advisory is at the core of every fundamental decision, Ceyeber has created a Medical Advisory Board consisting of top ophthalmologists. "We are thrilled to engage such leading ophthalmologists in this very exciting endeavor in advanced human cybernetics through ocular smart implantable technologies." The following are the members of Ceyeber's Advisory Board. Ceyeber's founder and CEO, Rob...
UC Irvine scientists working on universal vaccine to attack all strains of coronavirus The same lab is developing a special patch that could prove to be a "game changer" in delivering the vaccine to all parts of the world Author: City News Service, Richard Allyn (Reporter) Published: 10:46 PM PST January 22, 2021 Updated: 10:46 PM PST January 22, 2021 IRVINE, Calif. — UC Irvine scientists are working on developing a vaccine that would attack all strains of COVID-19 as well as a potential breakthrough that would solve many of the problems relat...
IACTA Pharmaceuticals and Pharmaleads to Develop the World's First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain News provided by Share this article - License agreement aims to accelerate global development of DENKIs, leveraging expertise and resources of both companies IRVINE, Calif., PARIS, HONG KONG, Jan. 7, 2021 /PRNewswire/ -- IACTA Pharmaceuticals, Inc. ("IACTA") and Pharmaleads, with Pharmaleads Greater China, today announced they have entered into licensing agreements, with IACTA acquiring global rights to Phar...